Skip to Content

Federman & Sherwood Reminds Investors of the Approaching Deadline in the Class Action Lawsuit Against Sesen Bio, Inc.

To join this class action, please complete the following Investor Certification. 


    Plaintiff Certifies That:

    The following information is true and correct to the best of my knowledge, information and belief:

    1. I have reviewed the Complaint in this action and authorize the filing of this Certification as an exhibit to the Complaint, or any substantively similar complaint or amended complaint to be filed in the future. I retain the law office of Federman & Sherwood, and any other counsel with whom Federman & Sherwood deems appropriate to associate with, to pursue this action on my behalf on a contingency fee basis.

    2. If chosen, I am willing to serve as a representative party on behalf of the class (the “Class”), either individually or as part of a group on behalf of the Class as defined in the Complaint, including providing testimony at deposition or trial (if necessary). I am also willing to participate on an executive committee of shareholders.

    3. I made the following transaction(s) during the Class Period in Sesen Bio, Inc. (NASDAQ: SESN) securities (which are the subject of this action) as follows:


    4. I did not purchase these securities at the direction of my attorney or in order to participate in a lawsuit under the Securities Act of 1933 or the Securities Exchange Act of 1934.

    5. During the 3-year period preceding the date of this Certification, I have not sought to serve, nor have I served, as a representative to any party or on behalf of any class in any action arising under the Securities Act of 1933 or the Securities Exchange Act of 1934.

    6. I will not accept any payment if chosen to serve as a representative party on behalf of the Class beyond my pro rata share of an award to the Class, or as otherwise ordered and approved by the Court, except for such reasonable costs and expenses directly relating to my service as a representative of the Class and as ordered and approved by the Court.












    By clicking on the button below, I intend to sign and execute this agreement and retain Federman & Sherwood to proceed on Plaintiff’s behalf on a contingency basis.

    Oklahoma City, OK (September 24, 2021) – Federman & Sherwood reminds investors of the approaching deadline in the class action lawsuit against Sesen Bio, Inc. (NASDAQ: SESN) for potential securities law violations.  The allegations are of violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which December 21, 2020, to August 17, 2021.  More specifically, after the company announced their second quarter 2021 earnings, the shares of Sesen Bio traded up over 50% since the market opened on August 9, 2021. On August 13, 2021, Sesen Bio announced that the U.S. Food and Drug Administration (FDA) declined to approve the Company’s Biologics License Application (BLA) for its bladder cancer treatment Vicineum which resulted in a drastic drop in the stock.

    The lawsuit seeks to recover damages on behalf of all Sesen Bio investors who purchased common stock during the Class Period and endured a loss. You may move the Court no later than October 18, 2021 to serve as a lead plaintiff for the entire Class. 

    If you wish to obtain further information and participate in this or any other securities litigation, or should you have any questions regarding this notice or preservation of your rights, please contact:  Priscilla Scoggins at pms@federmanlaw.com

    let’s connect

    Click Here to Complete Federman & Sherwood Fee Agreement.

    OKLAHOMA Office

    10205 North Pennsylvania Avenue
    Oklahoma City, Oklahoma 73120

    TEXAS Office

    212 W. Spring Valley Road,
    Richardson, Texas 75081